Eli Lilly and Company · 2 weeks ago
Advisor Research Scientist (Purification) - ADN RAMP Team
Indianapolis, IN
Full-time
Onsite
Senior Level
$114K/yr - $198K/yr
5+ years expEli Lilly and Company is a global healthcare leader headquartered in Indianapolis, Indiana. The Advisor Research Scientist will support the startup of new API Dry Product sites by leading the transfer of new molecules into production and improving existing processes focused on purification of peptides.
BiotechnologyHealth CareMedicalPharmaceutical
Responsibilities
Lead the successful transfer of new molecules into production at Lilly Sites
Leverage internal and external expertise to improve existing production processes focused on purification of peptides
Establish a world class methodology to ensure new manufacturing processes are robust, cost effective and can be transitioned safely and rapidly into production
Maintain a thorough understanding of the state of the art of manufacturing and regulatory requirements and build these into our processes
Develop strong working relationships with both R&D and plant sites to ensure success
Serves as a member of multidisciplinary product development teams responsible for the commercial scale development of new processes. He/she typically directs the laboratory activities and development of one or more junior staff members
Participate in the Science Lead Team– part of scientific governance/oversight for Lilly sites
Provide technical oversight to the Post Launch Optimization Team (PLOT) and other relevant TS/MS technical projects. Be the technical steward on all products they are accountable for
Define and lead TS/MS technical projects (experimental, modelling and/or production data analysis) to improve process control, yield, purity and/or productivity
Qualification
Required
BSc/MSc/PhD in Chemistry/Biochemistry or related science discipline
BSc requires 10+ years of industrial experience. MSc/PhD requires 5+ years of industrial experience
Deep technical interest and understanding in manufacturing operational excellence principles
Demonstrated ability to commercialize and solve manufacturing problems
Hands on experience supporting production at different scales from both a commercialization and supply perspective
Proven track record of working with diverse groups across the value chain and in multiple locations
Understanding the interaction of bulk drug substance and drug product formulation interaction of equipment set(s) with process (drug substance and drug product)
Significant experience with registration, including authoring of technical reports, Development History Report, regulatory responses, or direct interactions with regulatory agencies
Preferred
Excellent verbal and written communications skills
Strong analytical and problem-solving skills
Collaborative skills with operations, automation, and other process team members
Ability to coach others
Ability to influence without authority
Ability to clarify and simplify complex issues
Strong trust building with peers and leaders
Willing to work off-shift hours as needed to support project milestones and training of new employees
Benefits
Company bonus
Company-sponsored 401(k)
Pension
Vacation benefits
Medical, dental, vision and prescription drug benefits
Flexible benefits (e.g., healthcare and/or dependent day care flexible spending accounts)
Life insurance and death benefits
Certain time off and leave of absence benefits
Well-being benefits (e.g., employee assistance program, fitness benefits, and employee clubs and activities)
Company
Eli Lilly and Company
We're a medicine company turning science into healing to make life better for people around the world.
10001+ employees
H1B Sponsorship
Eli Lilly and Company has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (514)
2024 (236)
2023 (167)
2022 (133)
2021 (57)
2020 (52)
Funding
Current Stage
Public CompanyTotal Funding
$6.5M2024-02-12Post Ipo Debt· $6.5M
1978-01-13IPO
Leadership Team
David Ricks
Chair, CEO
Lucas Montarce
Executive Vice President and Chief Financial Officer
Recent News
Company data provided by crunchbase